JP2000515133A5 - - Google Patents

Download PDF

Info

Publication number
JP2000515133A5
JP2000515133A5 JP1998504453A JP50445398A JP2000515133A5 JP 2000515133 A5 JP2000515133 A5 JP 2000515133A5 JP 1998504453 A JP1998504453 A JP 1998504453A JP 50445398 A JP50445398 A JP 50445398A JP 2000515133 A5 JP2000515133 A5 JP 2000515133A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998504453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000515133A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/011576 external-priority patent/WO1998000137A1/en
Publication of JP2000515133A publication Critical patent/JP2000515133A/ja
Publication of JP2000515133A5 publication Critical patent/JP2000515133A5/ja
Ceased legal-status Critical Current

Links

JP10504453A 1996-07-01 1997-06-30 血糖降下性および脂質低下性の化合物 Ceased JP2000515133A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2101696P 1996-07-01 1996-07-01
US60/021,016 1996-07-01
PCT/US1997/011576 WO1998000137A1 (en) 1996-07-01 1997-06-30 Hypoglycemic and hypolipidemic compounds

Publications (2)

Publication Number Publication Date
JP2000515133A JP2000515133A (ja) 2000-11-14
JP2000515133A5 true JP2000515133A5 (enExample) 2005-03-10

Family

ID=21801854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10504453A Ceased JP2000515133A (ja) 1996-07-01 1997-06-30 血糖降下性および脂質低下性の化合物

Country Status (8)

Country Link
US (3) US6194446B1 (enExample)
EP (1) EP0925063A4 (enExample)
JP (1) JP2000515133A (enExample)
AU (1) AU3719997A (enExample)
CA (1) CA2259487A1 (enExample)
IL (1) IL121202A (enExample)
WO (1) WO1998000137A1 (enExample)
ZA (1) ZA975865B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
JP3215048B2 (ja) 1996-04-03 2001-10-02 日本たばこ産業株式会社 プロピオン酸誘導体及びその用途
RU2174121C2 (ru) 1996-08-19 2001-09-27 Джапан Тобакко Инк. Производные пропионовой кислоты и фармацевтическая композиция на их основе
PT1025077E (pt) * 1997-10-15 2007-05-31 Wyeth Corp Novas ariloxi-alquil-dialquilaminas
US6005102A (en) 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
US6221902B1 (en) 1998-05-12 2001-04-24 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
DE69904041D1 (de) * 1998-05-12 2003-01-02 Wyeth Corp Biphenylsulfonylarylcarbonsäuren verwendbar zur behandlung von insulin resistenz und hyperglycemia
AR016257A1 (es) * 1998-05-14 2001-06-20 Merck & Co Inc Proceso para la sintesis estereoselectiva de ariloxi-4-aza-5alfa-androstan-3-onas, 16 alfa y 16 beta-sustituidas e insustituidas, e intermediariosobtenidos en dicho proceso.
US6589969B1 (en) * 1998-10-16 2003-07-08 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives and drugs containing the same as the active ingredient
US6310081B1 (en) * 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
EP1078923B1 (en) 1999-08-02 2006-03-08 F. Hoffmann-La Roche Ag Process for the preparation of benzothiophene derivatives
US6414002B1 (en) 1999-09-22 2002-07-02 Bristol-Myers Squibb Company Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
TWI302149B (en) 1999-09-22 2008-10-21 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
MXPA02005528A (es) * 1999-12-03 2002-09-02 Kyoto Pharma Ind Compuestos heterociclicos sus sales y uso medicinal.
WO2002096904A1 (en) 2001-05-29 2002-12-05 Kyoto Pharmaceutical Industries, Ltd. Novel heterocyclic derivatives and medicinal use thereof
CZ20033450A3 (cs) 2001-05-29 2004-05-12 Kyotoápharmaceuticaláindustriesźáltd Heterocyklická sloučenina a její lékařské použití
JP4705756B2 (ja) * 2002-02-07 2011-06-22 仁 遠藤 芳香族アミノ酸誘導体及び医薬組成物
US6716842B2 (en) 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
JP4579681B2 (ja) 2002-07-09 2010-11-10 ブリストル−マイヤーズ スクイブ カンパニー 抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法
CN100467456C (zh) * 2004-05-24 2009-03-11 北京摩力克科技有限公司 作为hPPARα和/或hPPARγ激活剂的α-哌嗪取代的苯丙酸衍生物
CN100436430C (zh) * 2004-05-24 2008-11-26 北京摩力克科技有限公司 作为hPPARα和hPPARγ激动剂的烷酰基取代的酪氨酸衍生物
WO2008081537A1 (ja) * 2006-12-28 2008-07-10 Human Cell Systems, Inc. Lat1阻害活性を有する芳香族アミノ酸誘導体、それを含有するlat1阻害活性剤及びその製造方法
WO2017192455A1 (en) 2016-05-02 2017-11-09 Cardiac Pacemakers, Inc. Battery lithium cluster growth control
CN109996541A (zh) 2016-09-07 2019-07-09 普利安特治疗公司 N-酰基氨基酸化合物及其使用方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01139528A (ja) 1987-11-24 1989-06-01 Showa Denko Kk 抗潰瘍剤
US5036079A (en) 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
IL99537A (en) 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239846A (en) 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
KR0180248B1 (ko) 1991-06-07 1999-03-20 오오쓰까 아끼히꼬 항당뇨병약품
US5204350A (en) 1991-08-09 1993-04-20 Merck & Co., Inc. Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives
US5312923A (en) * 1992-02-28 1994-05-17 Merck & Co., Inc. Process for preparing fibrinogen receptor antagonists
US5206373A (en) 1992-02-28 1993-04-27 Merck & Co., Inc. Process for preparing fibrinogen receptor antagonists
US5246943A (en) 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
JP2759228B2 (ja) 1992-05-21 1998-05-28 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
US5236934A (en) 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
GB9225386D0 (en) 1992-12-04 1993-01-27 Smithkline Beecham Plc Novel compounds
GB9311661D0 (en) 1993-06-05 1993-07-21 Smithkline Beecham Plc Novel compounds
GB9311644D0 (en) 1993-06-05 1993-07-21 Smithkline Beecham Plc Novel compounds
US5491159A (en) * 1994-08-30 1996-02-13 American Home Products Corporation 2-(3,5-di-tert-butyl-4-hydroxy-phenyl)-oxazoles as anti-atherosclerotic agents
JP3485375B2 (ja) 1995-02-17 2004-01-13 株式会社資生堂 皮膚外用剤
JPH08325263A (ja) * 1995-05-31 1996-12-10 Sumitomo Metal Ind Ltd 新規2−アミノ−3−フェニルプロピオン酸誘導体
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
RU2174121C2 (ru) * 1996-08-19 2001-09-27 Джапан Тобакко Инк. Производные пропионовой кислоты и фармацевтическая композиция на их основе
US6059964A (en) * 1998-12-03 2000-05-09 Alpine Stormwater Management Company Collapsible catch basin grate filter assembly

Similar Documents

Publication Publication Date Title
JP2000507142A5 (enExample)
JP2000506265A5 (enExample)
JP2000506628A5 (enExample)
JP2000507458A5 (enExample)
JP2000509541A5 (enExample)
JP2000516511A5 (enExample)
JP2001507864A5 (enExample)
JP2000511377A5 (enExample)
JP2000506667A5 (enExample)
JP2000507117A5 (enExample)
JP2001509135A5 (enExample)
JP2000511527A5 (enExample)
JP2000511016A5 (enExample)
JP2002512662A5 (enExample)
JP2000507745A5 (enExample)
JP2000507939A5 (enExample)
JP2000506861A5 (enExample)
JP2000507578A5 (enExample)
JP2000503288A5 (enExample)
JP2001504461A5 (enExample)
JP2000507412A5 (enExample)
JP2000507952A5 (enExample)
JP2000504051A5 (enExample)
JP2001501952A5 (enExample)
JP2000507011A5 (enExample)